Navigation Links
Dana Farber/Harvard Cancer Center awarded $11.7M grant to support prostate cancer research
Date:12/27/2010

BOSTON--Dana Farber/Harvard Cancer Center (DF/HCC) will launch a new multi-million dollar grant award program focused on prostate cancer research. It will be administered in collaboration with the Prostate Cancer Foundation (PCF).

Judge Richard G. Stearns of the United States District Court for the District of Massachusetts awarded DF/HCC approximately $11.7 million in a cy pres ("near as possible") distribution of unclaimed funds from the settlement of a nationwide class action involving the marketing of the cancer drug Lupron(R). Judge Stearns made the award to DF/HCC after reviewing a number of proposals solicited from class members and the public.

The DF/HCC grant program will emphasize large-scale research collaborations on a national level and smaller-scale innovative pilot projects as well as research conducted by promising young investigators and talented graduate students. The goal is to catalyze innovative and collaborative research that will translate to meaningful clinical advances for prostate cancer patients and others.

"It is our vision that this program will further our scientific and clinical understanding of prostate cancer, lead to better and new treatments, and provide critical funds to young investigators to help them develop into the next generation of prostate cancer researchers," said Philip Kantoff, M.D, director of DF/HCC prostate cancer program.

Under the direction of Kantoff, who also leads the prostate cancer program at Dana-Farber Cancer Institute, the A. David Mazzone Awards Program will primarily fund research in the causes of prostate cancer as well as research in other diseases, like precocious puberty, for which Lupron has proven an effective treatment. The program leverages existing DF/HCC infrastructure and funding mechanisms, as well as a longstanding, collaborative relationship with PCF. DF/HCC and PCF will each administer research funds through their respective competitive grant programs. A call for applications is expected to occur in early 2011.


'/>"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
Source:Eurekalert

Related medicine news :

1. Gene Mutation Found in One of Four Cases of Deadly Brain Cancers
2. Penn researchers identify potential target for breast cancer therapy
3. Cancer Cells May Be Able to Urge Their Own Death
4. Recurrence of Oral Cancer Found to Signal Poor Outcome
5. Age plays too big a role in prostate cancer treatment decisions
6. UH biochemist works to revolutionize ovarian cancer treatment
7. Smoking may worsen pain for cancer patients
8. Tumor cells in blood may signal worse prognosis in head and neck cancer patients
9. Factors linked to speech/swallowing problems after treatment for head and neck cancers
10. Blacks with liver cancer more likely to die, study finds
11. Robotic surgery for head and neck cancer shows promise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon ... proud to announce a new informational post on robotic hair transplantation. San Francisco ... (FUE) hair transplant and Follicular Unit Transplantation (FUT) can sound similar. Either treatment ...
(Date:2/27/2017)... ... , ... New Jersey ranks among the top five states in the entire ... for advanced services is growing. , Project WE vs C is a focused ... their non-profit partners in their fight against cancer and in support of their shared ...
(Date:2/26/2017)... , ... February 26, 2017 , ... ... for entries to the 7th Edition of International Social Design Awards. , ... Professionals, Product Designers, System Designers, Governments and Institutions worldwide with realized projects and ...
(Date:2/26/2017)... ... February 26, 2017 , ... NuevaCare, a leading home care agency ... Belmont, and Palo Alto, is proud to announce an important upgrade to its geographic ... for home care close to home, and by having city-specific pages, NuevaCare is answering ...
(Date:2/26/2017)... ... 26, 2017 , ... IndustryArchive.Org . is announcing a new way for ... will now only pay for B.A.N.T. quality sales leads based on the Sellers decision ... the new reality that B2B buyers are controlling the sales process via the Internet ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... 27, 2017  Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), ... of select chronic diseases utilizing its ProNeura™ long-term, ... U.S. Food & Drug Administration (FDA) has completed ... New Drug Application (IND) and has requested that ... pending submission of the requested information and the ...
(Date:2/28/2017)... Md. and RESEARCH TRIANGLE PARK, N.C. ... (NASDAQ: UTHR ) announced today that Martine ... Therapeutics, will provide an overview and update on the company,s ... Health Care Conference in Boston, Massachusetts . ... 6, 2017, at 2:00 PM Eastern Time, and can be ...
(Date:2/28/2017)... Feb. 27, 2017 This report provides all ... its partnering interests and activities since 2010. ... Description The Partnering Deals and Alliance since 2010 report ... one of the world,s leading life sciences companies. ... to ensure inclusion of the most up to date ...
Breaking Medicine Technology: